# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: K083655   
B. Purpose for Submission: New calibration test system   
C. Measurand: Toxoplasma gondii (T. gondii)   
D. Type of Test: Calibration Verification Material for Toxoplasma IgG   
E. Applicant: Roche Diagnostics   
F. Proprietary and Established Names: Elecsys Toxo IgG CalCheck; Toxo IgG CalCheck

# G. Regulatory Information:

1. Regulation section: 862.1660- Quality control material (assayed and unassayed) 866.3780 - Toxoplasma gondii serological reagents

2. Classification: Class I Class II

3. Product code:

JJX- Quality Control Material (assayed and unassayed)

LGD- Toxoplasma gondii serological reagents

4. Panel: 75- Clinical Chemistry 83- Microbiology

# H. Intended Use:

1. Intended use(s):

The Elecsys Toxo IgG CalCheck, an assayed calibrator control, is intended for use in the verification of the calibration established by the Elecsys Toxo IgG reagent on the Elecsys 2010, the MODULAR ANALYTICS E170, and cobas e immunoassay analyzers.

2. Indication(s) for use:

The Elecsys Toxo IgG CalCheck, an assayed calibrator control, is intended for use in the verification of the calibration established by the Elecsys Toxo IgG reagent on the Elecsys 2010, the MODULAR ANALYTICS E170, and cobas e immunoassay analyzers.

3. Special condition for use statement(s): To be used with the Elecsys Toxo IgG assay.

4. Special instrument requirements: Elecsys 2010, MODULAR ANALYTICS E170 or cobas e analyzers.

# I. Device Description:

The Elecsys Toxo IgG CalCheck is a lyophilized product consisting of human anti-Toxo IgG antibodies in human serum matrix. During manufacture, the analytes are spiked into the matrix at the desired concentration levels.

# J. Substantial Equivalence Information:

1. Predicate device name(s):

• Elecsys C-Peptide CalCheck

2. Predicate 510(k) number(s):

K040157

3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>DeviceElecsys Toxo IgGCalCheck</td><td rowspan=1 colspan=1>PredicateElecsys C-PeptideCalCheck(K040157)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For use in the verification ofthe calibration establishedby the Elecsys Toxo IgGreagent on the Elecsys andcobas e immunoassayanalyzers.</td><td rowspan=1 colspan=1>For use in the verificationof the calibrationestablished by the ElecsysC-Peptide reagent on theElecsys and cobas eimmunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Indications for Use</td><td rowspan=1 colspan=1>For use in the verification ofthe calibration establishedby the Elecsys Toxo IgGreagent on the Elecsys andcobas e immunoassayanalyzers.</td><td rowspan=1 colspan=1>For use in the verificationof the calibrationestablished by the ElecsysC-Peptide reagent on theElecsys and cobas eimmunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Three</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Lyophilized</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Reconstitute with exactly1.0 mL distilled ordeionized water and allowstanding closed for 15minutes, then mix gently.</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Unopened: Store at 2-8°Cuntil expiration dateReconstituted: 20 - 25°C :4 hrs</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>DeviceElecsys Toxo IgGCalCheck</td><td rowspan=1 colspan=1>PredicateElecsys C-PeptideCalCheck(K040157)</td></tr><tr><td rowspan=1 colspan=1>Matrix Analyte</td><td rowspan=1 colspan=1>Human Serum anti- ToxoIgG</td><td rowspan=1 colspan=1>equine serum matrix anti-CCP</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

This 510(k) Premarket Notification was prepared and referenced the following guidance documents and recognized standards:

Guidance for Industry and FDA Staff - Assayed and Unassayed Quality Control Material (DRAFT final: June 7, 2007)

No Standard document was referenced.

L. Test Principle: Not applicable.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance: a. Precision/Reproducibility: Not applicable. b. Linearity/assay reportable range: Not applicable. c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Values for Toxo IgG CalCheck are calibrated against the WHO anti-Toxoplasma serum (TOXM), $3 ^ { \mathrm { { r d } } }$ International Standard for T. gondii from the National Institute for Biological Standards and Control (NIBSC), UK. Values are assigned using a minimum of 3 Elecsys 2010/ cobas e 411 analyzers, 3 MODULAR ANALYTICS E170/ cobas e601 analyzers. Two independent series of analyses are performed for each instrument. The target value is then calculated as the median of the determined values.

d. Detection limit: Not applicable.   
e. Analytical specificity: Not applicable.   
f. Assay cut-off:

The assay cut-off was determined using a master calibrators for the assay that has values assigned that are traceable to the World Health Organizations (WHO)

standards. The sponsor used the WHO anti-Toxoplasma serum (TOXM), $3 ^ { \mathrm { r d } }$ International Standard for T. gondii from NIBSC, UK. Two independent series of analyzes were performed on the Elecsys 2010, cobas e 411, and the MODULAR ANALYTICS E170/ cobas e601 analyzers. The samples were run in duplicate and the target values were calculated as the median of the determined values. This fulfils the requirements of demonstrating a target values for the Toxo IgG CalCheck levels calibrators.

<table><tr><td rowspan=1 colspan=1>Toxo IgG CalCheck Level</td><td rowspan=1 colspan=1>Toxo IgG Target Values(IU/mL)</td></tr><tr><td rowspan=1 colspan=1>Check 1 (low)</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Check 2 (medium)</td><td rowspan=1 colspan=1>325</td></tr><tr><td rowspan=1 colspan=1>Check 3 (high)</td><td rowspan=1 colspan=1>520</td></tr></table>

2. Comparison studies:

a. Method comparison with predicate device: Not applicable.

b. Matrix comparison: Not applicable.

3. Clinical studies:

a. Clinical Sensitivity: Not applicable.   
b. Clinical specificity: Not applicable.   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable.

4. Clinical cut-off: Not applicable.

5. Expected values/Reference range:

Representative values are assigned to lots 15273499, 17922999, and 17923099 of the product. Composition: The Anti HBs CalCheck calibration verification solutions consists of 3 CalCheck solutions; low, medium and high, each with a defined Toxo IgG CalCheck level. This information is included in the package insert.

<table><tr><td rowspan=1 colspan=1>Toxo IgG CalCheck Level</td><td rowspan=1 colspan=1>Toxo IgG Assigned Values andRanges</td></tr><tr><td rowspan=1 colspan=1>Check 1 (low)</td><td rowspan=1 colspan=1>2.73 IU/mL(1.91- 3.55)</td></tr><tr><td rowspan=1 colspan=1>Check 2 (medium)</td><td rowspan=1 colspan=1>315 IU/mL(189-441)</td></tr><tr><td rowspan=1 colspan=1>Check 3 (high)</td><td rowspan=1 colspan=1>500 IU/mL(300-700)</td></tr></table>

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The information submitted in this premarket notification is complete and supports a substantial equivalent decision.